Home/Filings/4/0001567619-19-001863
4//SEC Filing

RAY DEBANJAN 4

Accession 0001567619-19-001863

CIK 0001501989other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 6:57 PM ET

Size

5.6 KB

Accession

0001567619-19-001863

Insider Transaction Report

Form 4
Period: 2019-01-25
RAY DEBANJAN
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-25+90,00090,000 total
    Exercise: $16.85Exp: 2029-01-24Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2019 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001706863

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:57 PM ET
Size
5.6 KB